U.S. Futures rose due to news of coronavirus treatment

U.S. Futures jumped on Wednesday over reports of a medical breakthrough in the fight against the rapidly spreading coronavirus and expectations of a greater incentive for China to curb the economic downturn.

A Chinese university has found an effective drug to treat people with the new virus, according to a report on local television. Separately, UK researchers have told Sky news that they have made a “significant breakthrough” in finding the vaccine.

However, the World Health Organization denied the reports, saying that “there are no known effective treatments for this virus.

United Airlines (UAL.US) and American Airlines Group (AAL.US) simultaneously stopped all flights to and from Hong Kong, leaving virtually no American aircraft carrying passengers to the Asian Financial Center. Their shares increased by 1.8% and 1.2% respectively in trading on the market.

Dow e-minis rose 221 points, or 0.77%.

The S&P 500 e-minis rose 24.25 points or 0.73%.

The Nasdaq 100 e-minis was in positive territory by 85 points, or 0.91%.

Coty Inc. (COTY.US) rose 8.6% as the cosmetics maker shattered its quarterly earnings and revenue expectations.

But Ford Motor Co (F.US) fell 7.8% after the US carmaker No. 2 gave a lower-than-expected 2020 estimate.

Snap Inc (SNAP.US) fell 9% after the owner of the popular photo messaging app Snapchat missed quarterly earnings expectations.

 Trader Milko Zashev

Read more:
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance